ANGELINI Alessandro

Position
Associate Professor
Telephone
Laboratorio: 041 234 8944 / Laboratorio: 041 234 8590 / Studio personale: 041 234 8600 / Uff. dottorandi e ricercatori: 041 234 8604
E-mail
alessandro.angelini@unive.it
Scientific sector (SSD)
BIOCHIMICA [BIO/10]
Website
www.unive.it/persone/alessandro.angelini (personal record)
Office
Department of Molecular Sciences and Nanosystems
Website: https://www.unive.it/dep.dsmn
Where: Campus scientifico via Torino (edificio Alfa)
Room: office 710 (Alfa building, 7th floor) / research lab 1 (Beta building, 3rd floor)
Office
European Center for Living Technology (ECLT)
Where: Ca' Bottacin
Research Institute
Research Institute for Complexity

Activities and research skills

Scientific sector (SSD)
BIOCHIMICA [BIO/10]
Geographic areas in which the research experience mainly applies
Internazionale: Europa, America Settentrionale
Known languages
Italiano (scritto: madrelingua parlato: madrelingua)
Inglese (scritto: avanzato parlato: avanzato)
Participation in editorial boards of scientific journals/book series
2022 – present: Associate editor for Frontiers Molecular Biosciences
Participation as referees of national and international research projects
1. Referee for research grant application proposals to the Dutch Research Council (NOW – Netherlands)
2. Referee for research grant application proposals to the Auckland Medical Research Foundation (AMRF – New Zealand)
Areas and research fields
Area: Biomedicina Linea: Terapia
Evoluzione molecolare di peptidi e proteine
Description:
Molecular evolution of peptides and proteins
Keywords:
Applied biology, Molecular evolution, Structural biology
ATECO code:
[72.11] - ricerca e sviluppo sperimentale nel campo delle biotecnologie
Sviluppo di nuove tecnologie per evoluzione diretta di biomolecole codificate geneticamente
Description:
Development of novel technologies for the directed evolution of genetically encoded biomolecules
Keywords:
Biochemical technology, Genetic selection, Genetically modified organisms
ATECO code:
[72.11] - ricerca e sviluppo sperimentale nel campo delle biotecnologie
Bioingegneria di peptidi e proteine terapeutiche
Description:
Bioengineering of therapeutic peptides and proteins
Keywords:
Molecular design, de novo design, Monoclonal antibodies, Molecular markers and recognition
ATECO code:
[72.11] - ricerca e sviluppo sperimentale nel campo delle biotecnologie
Development and characterisation of macrocyclic peptides
SSD:
BIO/10
Other members of the research group:
Stefano PERIN
Development of novel directed evolution methodologies and recombinant surface display technologies
SSD:
BIO/10
Other members of the research group:
Sara LINCIANO
Selection and engineering of antibodies and nanobodies
SSD:
BIO/10
Other members of the research group:
Zhanna ROMANYUK
Selection and engineering of genetically encoded peptides
SSD:
BIO/10
Other members of the research group:
Ylenia MAZZOCATO
Class IIa HDACs as therapeutic targets in human diseases: new roles and new selective inhibitors
Funding body:
Ministry of Education, University and Research (MIUR)
Type:
PRIN
Role in the project:
PT
Starting date:
Year: 2019 Length in months: 36
Il criceto dorato (Mesocricetus auratus) come modello animale per l’utilizzo di anticorpi monoclonali a scopo terapeutico per le malattie infettive a carattere zoonosico
Funding body:
The Ministry of Health
Type:
Altri programmi ministeriali
Role in the project:
PT
Starting date:
Year: 2020 Length in months: 24
Macrocyclic peptides targeting unexplored class IIa HDAC binding sites: towards the development of novel cancer therapy
Funding body:
Fondazione AIRC per la Ricerca sul Cancro e Commissione Europea (Horizon 2020)
Type:
Altri finanziamenti per progetti di ricerca
Role in the project:
LD
Starting date:
Year: 2020 Length in months: 36
Novel molecular target for diagnosis and therapy in early esophageal cancer
Funding body:
The Ministry of Health
Type:
Altri programmi ministeriali
Role in the project:
PT
Starting date:
Year: 2021 Length in months: 36
Reducing SARS-CoV-2 spread in the human body via the aerosolized delivery of cell-shielding PEGylated bicyclic peptides (RELIEVED)
Funding body:
Ministry of Education, University and Research (MIUR)
Type:
FIRB/FIR/SIR
Role in the project:
LD
Starting date:
Year: 2021 Length in months: 6